ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.691,32
0,05%
S&P 500
5.276,75
-0,57%
Dow Jones
39.128,04
-1,37%
Euro vs US Dollar
1,08127
-0,11%
Bitcoin
67.584,45
-2,19%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. 23andMe Holding Company (ME)

  7. 23andMe Holding Company (ME) News

ME

23andMe (ME)

23andMe Holding Company
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ME
DatumZeitQuelleÜberschriftSymbolFirma
21/05/202422h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ME23andMe Holding Company
21/05/202422h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ME23andMe Holding Company
14/05/202413h00GlobeNewswire Inc.Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros PharmaceuticalsNASDAQ:ME23andMe Holding Company
10/05/202422h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
09/05/202422h50GlobeNewswire Inc.23andMe to Report Q4 and Full Year FY2024 Financial ResultsNASDAQ:ME23andMe Holding Company
30/04/202417h00Business WirePotter Handy Law Firm Represents Nearly 5,000 Clients in 23andMe Data Breach CaseNASDAQ:ME23andMe Holding Company
24/04/202422h05GlobeNewswire Inc.23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:ME23andMe Holding Company
18/04/202414h00GlobeNewswire Inc.23andMe announces CEO’s intention to pursue a potential take-privateNASDAQ:ME23andMe Holding Company
05/04/202422h05GlobeNewswire Inc.23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024NASDAQ:ME23andMe Holding Company
20/03/202412h30GlobeNewswire Inc.23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6NASDAQ:ME23andMe Holding Company
19/03/202413h00GlobeNewswire Inc.23andMe Launches New Feature Connecting Customers to Historical Individuals from Hundreds and Even Thousands of Years AgoNASDAQ:ME23andMe Holding Company
06/03/202413h30GlobeNewswire Inc.23andMe Launches New Genetic Reports on Common Forms of CancerNASDAQ:ME23andMe Holding Company
05/03/202422h30GlobeNewswire Inc.23andMe Announces Three Presentations from Clinical-Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024NASDAQ:ME23andMe Holding Company
21/02/202422h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ME23andMe Holding Company
07/02/202422h07Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ME23andMe Holding Company
07/02/202422h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
07/02/202422h01GlobeNewswire Inc.23andMe Reports Third Quarter Fiscal 2024 Financial ResultsNASDAQ:ME23andMe Holding Company
06/02/202413h00Business WireMoneta Gold and Nighthawk Gold Complete At-Market Merger to form STLLR Gold Inc.NASDAQ:ME23andMe Holding Company
31/01/202413h50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
31/01/202404h12GlobeNewswire Inc.23andMe Launches Month-Long Initiative to Amplify ARRAY’s “Seat16” Program for Acclaimed Film ORIGIN by Ava DuVernayNASDAQ:ME23andMe Holding Company
30/01/202423h00Business WireNighthawk Gold Obtains Final Court Order for the Proposed ArrangementNASDAQ:ME23andMe Holding Company
24/01/202422h05GlobeNewswire Inc.23andMe to Report FY2024 Third Quarter Financial ResultsNASDAQ:ME23andMe Holding Company
22/01/202414h00Business WireMoneta Gold and Nighthawk Gold Announce the Proposed Directors for the MergeCo BoardNASDAQ:ME23andMe Holding Company
08/01/202413h45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
19/12/202314h00GlobeNewswire Inc.23andMe announces further expansion of 23ME-00610 Phase 1/2a clinical trial in advanced neuroendocrine and ovarian cancer patient cohortsNASDAQ:ME23andMe Holding Company
01/12/202322h06Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ME23andMe Holding Company
28/11/202313h15Business WireNighthawk and Moneta Announce At-Market Merger to Create a Leading Canadian Gold Development CompanyNASDAQ:ME23andMe Holding Company
21/11/202322h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ME23andMe Holding Company
21/11/202322h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ME23andMe Holding Company
13/11/202322h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
 Showing the most relevant articles for your search:NASDAQ:ME

Kürzlich von Ihnen besucht

BIT
P20BJ0
NLBNPIT20BJ0 20241220 3.2
BIT
P1YD41
NLBNPIT1YD41 20991231 15...
NYSE
DUR
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten